Evozym Biologics and GenScript Form Strategic Collaboration
News Jun 03, 2011
The companies intend to develop next generation proteins and enzymes by combining Evozym Biologics’ innovative enzyme/protein design capabilities with GenScript’s gene synthesis and protein expression capabilities.
“GenScript is a premier CRO and DNA synthesis company,” noted Joseph Grzymski co-founder and President of Evozym. “We are incredibly excited to introduce them to our protein evolution and computational design platforms. We believe our collaboration will allow both companies to leverage strengths and create next generation bio-products efficiently and cost-effectively.”
Small imperfections in a wine glass or tiny creases in a contact lens can be tricky to make out, even in good light. In almost total darkness, images of such transparent features or objects are nearly impossible to decipher. But now, engineers at MIT have developed a technique that can reveal these “invisible” objects, in the dark.
For scientists wrestling with problems as diverse as containing superhot plasma in a fusion reactor, improving the accuracy of weather forecasts, or probing the unexplained dynamics of a distant galaxy, turbulence-spawning shear flow is a serious complicating factor. A new supercomputer-powered effort aims to make modelling shear far easier.
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019